Bone resorption and fracture across the menopausal transition
Authors:
- Jane A. DrPH CauleyJCJane A. DrPH Cauley
- Joel S. FinkelsteinJFJoel S. Finkelstein
- Joan C. LoJLJoan C. Lo
- Robert M. NeerRNRobert M. Neer
- Kristine DrPH RuppertKRKristine DrPH Ruppert
- 1 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 19 (11) , 1200-1207
Abstract
Objective Bone turnover markers (BTMs) predict fracture in older women, whereas data on younger women are lacking. To test the hypothesis that BTMs measured before and after menopause predict fracture risk, we performed a cohort study of 2,305 women. Methods Women attended up to nine clinic visits for an average of 7.6 ± 1.6 years; all were aged 42 to 52 years and were premenopausal or early perimenopausal at baseline. Incident fractures were self-reported. Serum osteocalcin and urinary cross-linked N-telopeptide of type I collagen (NTX) were measured at baseline. NTX was measured at each annual follow-up. Interval-censored survival models or generalized estimating equations were used to test whether baseline BTMs and changes in NTX, respectively, were associated with fracture risk. Hazard ratios (HRs) or odds ratios were calculated with 95% CIs. Results Women who experienced fractures (n = 184) had about a 10% higher baseline median NTX (34.4 vs 31.5 nanomoles of bone collagen equivalents per liter per nanomole of creatinine per liter; P = 0.001), but there was no difference in osteocalcin. A 1-SD decrease in lumbar spine bone mineral density (BMD) measured premenopausally was associated with a higher fracture risk during menopause (HR, 1.50; 95% CI, 1.28-1.68). Women with a baseline NTX greater than the median had a 45% higher risk of fracture, multivariable-adjusted (HR, 1.46; 95% CI, 1.05-2.26). The HR of fracture among women with both the lowest spine BMD (quartile 1) and the highest NTX (quartile 4) at baseline was 2.87 (95% CI, 1.61-6.01), compared with women with lower NTX and higher BMD. Women whose NTX increased more than the median had a higher risk of fracture (odds ratio, 1.51; 95% CI, 1.08-2.10). Women who had baseline NTX greater than the median experienced greater loss of spine and hip BMD. Conclusions A higher urinary NTX excretion measured before menopause and across menopause is associated with a higher risk of fracture. Our results are consistent with the pathophysiology of transmenopausal changes in bone strength.Keywords
This publication has 42 references indexed in Scilit:
- Ethnic differences in composite indices of femoral neck strengthOsteoporosis International, 2011
- Genetic polymorphisms and obesity influence estradiol decline during the menopauseClinical Endocrinology, 2010
- Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS StudyJournal of Bone and Mineral Research, 2009
- Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of WomenThe Journal of Clinical Endocrinology & Metabolism, 2008
- Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention TrialJournal of Bone and Mineral Research, 2006
- Endocrine regulation of bone turnover in menClinical Endocrinology, 2005
- Risk Factors for a First-Incident Radiographic Vertebral Fracture in Women ≥65 Years of Age: The Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 2005
- Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trialsMenopause, 2004
- Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly WomenJournal of Bone and Mineral Research, 2004
- BONE FORMATION AND RESORPTION IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1981